nodes	percent_of_prediction	percent_of_DWPC	metapath
Ritonavir—CYP2B6—Thiotepa—urinary bladder cancer	0.0555	0.0844	CbGbCtD
Ritonavir—ABCC1—Epirubicin—urinary bladder cancer	0.041	0.0624	CbGbCtD
Ritonavir—ABCB1—Mitomycin—urinary bladder cancer	0.0375	0.0571	CbGbCtD
Ritonavir—ABCC1—Etoposide—urinary bladder cancer	0.032	0.0486	CbGbCtD
Ritonavir—ABCC2—Carboplatin—urinary bladder cancer	0.0282	0.0428	CbGbCtD
Ritonavir—ABCG2—Fluorouracil—urinary bladder cancer	0.0256	0.039	CbGbCtD
Ritonavir—ABCG2—Carboplatin—urinary bladder cancer	0.0255	0.0387	CbGbCtD
Ritonavir—ABCC2—Cisplatin—urinary bladder cancer	0.0241	0.0366	CbGbCtD
Ritonavir—ABCC2—Etoposide—urinary bladder cancer	0.0237	0.036	CbGbCtD
Ritonavir—ABCC1—Doxorubicin—urinary bladder cancer	0.0218	0.0332	CbGbCtD
Ritonavir—ABCG2—Cisplatin—urinary bladder cancer	0.0218	0.0331	CbGbCtD
Ritonavir—ABCG2—Etoposide—urinary bladder cancer	0.0214	0.0325	CbGbCtD
Ritonavir—ABCC1—Methotrexate—urinary bladder cancer	0.0211	0.0321	CbGbCtD
Ritonavir—SLCO1A2—Methotrexate—urinary bladder cancer	0.0189	0.0287	CbGbCtD
Ritonavir—SLCO1B1—Methotrexate—urinary bladder cancer	0.0178	0.0271	CbGbCtD
Ritonavir—CYP3A4—Thiotepa—urinary bladder cancer	0.017	0.0259	CbGbCtD
Ritonavir—ABCC2—Doxorubicin—urinary bladder cancer	0.0161	0.0245	CbGbCtD
Ritonavir—ABCC2—Methotrexate—urinary bladder cancer	0.0156	0.0238	CbGbCtD
Ritonavir—CYP2B6—Cisplatin—urinary bladder cancer	0.0153	0.0233	CbGbCtD
Ritonavir—CYP2E1—Etoposide—urinary bladder cancer	0.0153	0.0232	CbGbCtD
Ritonavir—ABCG2—Doxorubicin—urinary bladder cancer	0.0146	0.0222	CbGbCtD
Ritonavir—ABCG2—Methotrexate—urinary bladder cancer	0.0141	0.0215	CbGbCtD
Ritonavir—CYP2C8—Fluorouracil—urinary bladder cancer	0.0137	0.0208	CbGbCtD
Ritonavir—CYP3A5—Etoposide—urinary bladder cancer	0.0119	0.018	CbGbCtD
Ritonavir—CYP2C8—Etoposide—urinary bladder cancer	0.0114	0.0173	CbGbCtD
Ritonavir—ABCB1—Gemcitabine—urinary bladder cancer	0.0108	0.0164	CbGbCtD
Ritonavir—CYP1A2—Fluorouracil—urinary bladder cancer	0.0106	0.0161	CbGbCtD
Ritonavir—CYP2B6—Doxorubicin—urinary bladder cancer	0.0103	0.0156	CbGbCtD
Ritonavir—CYP2C9—Fluorouracil—urinary bladder cancer	0.00952	0.0145	CbGbCtD
Ritonavir—CYP1A2—Etoposide—urinary bladder cancer	0.00882	0.0134	CbGbCtD
Ritonavir—CYP2C9—Cisplatin—urinary bladder cancer	0.00809	0.0123	CbGbCtD
Ritonavir—ABCB1—Cisplatin—urinary bladder cancer	0.00785	0.0119	CbGbCtD
Ritonavir—ABCB1—Etoposide—urinary bladder cancer	0.00771	0.0117	CbGbCtD
Ritonavir—ABCB1—Doxorubicin—urinary bladder cancer	0.00526	0.008	CbGbCtD
Ritonavir—ABCB1—Methotrexate—urinary bladder cancer	0.0051	0.00775	CbGbCtD
Ritonavir—CYP2D6—Doxorubicin—urinary bladder cancer	0.00496	0.00754	CbGbCtD
Ritonavir—CYP3A4—Etoposide—urinary bladder cancer	0.00462	0.00703	CbGbCtD
Ritonavir—CYP3A4—Doxorubicin—urinary bladder cancer	0.00315	0.00479	CbGbCtD
Ritonavir—CYP2C19—urine—urinary bladder cancer	0.00288	0.0633	CbGeAlD
Ritonavir—CYP1A2—urine—urinary bladder cancer	0.00236	0.0517	CbGeAlD
Ritonavir—CYP2C9—urine—urinary bladder cancer	0.00224	0.0491	CbGeAlD
Ritonavir—CYP2E1—urine—urinary bladder cancer	0.00212	0.0465	CbGeAlD
Ritonavir—CYP3A4—urine—urinary bladder cancer	0.00171	0.0374	CbGeAlD
Ritonavir—CYP2D6—urine—urinary bladder cancer	0.00168	0.0368	CbGeAlD
Ritonavir—SLC47A1—prostate gland—urinary bladder cancer	0.00161	0.0353	CbGeAlD
Ritonavir—SLC47A1—seminal vesicle—urinary bladder cancer	0.00136	0.0299	CbGeAlD
Ritonavir—ABCC2—prostate gland—urinary bladder cancer	0.0012	0.0265	CbGeAlD
Ritonavir—SLC47A1—renal system—urinary bladder cancer	0.0011	0.0241	CbGeAlD
Ritonavir—SLCO1B1—renal system—urinary bladder cancer	0.00108	0.0238	CbGeAlD
Ritonavir—SLC47A1—urethra—urinary bladder cancer	0.00108	0.0237	CbGeAlD
Ritonavir—ABCC1—prostate gland—urinary bladder cancer	0.00106	0.0233	CbGeAlD
Ritonavir—ABCC1—seminal vesicle—urinary bladder cancer	0.000898	0.0197	CbGeAlD
Ritonavir—SLCO1A2—renal system—urinary bladder cancer	0.000882	0.0194	CbGeAlD
Ritonavir—SLC47A1—female reproductive system—urinary bladder cancer	0.000879	0.0193	CbGeAlD
Ritonavir—ABCG2—prostate gland—urinary bladder cancer	0.000879	0.0193	CbGeAlD
Ritonavir—SLCO1B1—female reproductive system—urinary bladder cancer	0.000868	0.019	CbGeAlD
Ritonavir—ABCC2—renal system—urinary bladder cancer	0.000821	0.018	CbGeAlD
Ritonavir—CYP3A5—prostate gland—urinary bladder cancer	0.000816	0.0179	CbGeAlD
Ritonavir—SLC47A1—vagina—urinary bladder cancer	0.000795	0.0174	CbGeAlD
Ritonavir—CYP2E1—prostate gland—urinary bladder cancer	0.000761	0.0167	CbGeAlD
Ritonavir—ABCG2—seminal vesicle—urinary bladder cancer	0.000743	0.0163	CbGeAlD
Ritonavir—ABCC1—urethra—urinary bladder cancer	0.000711	0.0156	CbGeAlD
Ritonavir—ABCC2—female reproductive system—urinary bladder cancer	0.000658	0.0144	CbGeAlD
Ritonavir—CYP2E1—seminal vesicle—urinary bladder cancer	0.000643	0.0141	CbGeAlD
Ritonavir—CYP2C8—renal system—urinary bladder cancer	0.000616	0.0135	CbGeAlD
Ritonavir—ABCG2—urethra—urinary bladder cancer	0.000588	0.0129	CbGeAlD
Ritonavir—CYP1A2—renal system—urinary bladder cancer	0.000576	0.0127	CbGeAlD
Ritonavir—CYP3A5—renal system—urinary bladder cancer	0.000556	0.0122	CbGeAlD
Ritonavir—CYP2B6—renal system—urinary bladder cancer	0.000553	0.0121	CbGeAlD
Ritonavir—ABCC1—vagina—urinary bladder cancer	0.000524	0.0115	CbGeAlD
Ritonavir—CYP2E1—renal system—urinary bladder cancer	0.000519	0.0114	CbGeAlD
Ritonavir—SLC47A1—lymph node—urinary bladder cancer	0.000514	0.0113	CbGeAlD
Ritonavir—CYP2C19—vagina—urinary bladder cancer	0.000511	0.0112	CbGeAlD
Ritonavir—CYP2E1—urethra—urinary bladder cancer	0.000509	0.0112	CbGeAlD
Ritonavir—CYP2C8—female reproductive system—urinary bladder cancer	0.000493	0.0108	CbGeAlD
Ritonavir—CYP2C8—vagina—urinary bladder cancer	0.000446	0.0098	CbGeAlD
Ritonavir—CYP2B6—female reproductive system—urinary bladder cancer	0.000442	0.00972	CbGeAlD
Ritonavir—CYP2C9—female reproductive system—urinary bladder cancer	0.000438	0.00962	CbGeAlD
Ritonavir—ABCG2—vagina—urinary bladder cancer	0.000434	0.00952	CbGeAlD
Ritonavir—ABCB1—prostate gland—urinary bladder cancer	0.000433	0.00951	CbGeAlD
Ritonavir—CYP3A4—renal system—urinary bladder cancer	0.000417	0.00916	CbGeAlD
Ritonavir—CYP2E1—female reproductive system—urinary bladder cancer	0.000415	0.00912	CbGeAlD
Ritonavir—CYP2D6—renal system—urinary bladder cancer	0.000411	0.00901	CbGeAlD
Ritonavir—CYP3A5—vagina—urinary bladder cancer	0.000403	0.00884	CbGeAlD
Ritonavir—CYP2B6—vagina—urinary bladder cancer	0.0004	0.00879	CbGeAlD
Ritonavir—ABCC2—lymph node—urinary bladder cancer	0.000385	0.00845	CbGeAlD
Ritonavir—ABCB1—seminal vesicle—urinary bladder cancer	0.000366	0.00805	CbGeAlD
Ritonavir—ABCC1—lymph node—urinary bladder cancer	0.000339	0.00744	CbGeAlD
Ritonavir—CYP3A4—female reproductive system—urinary bladder cancer	0.000334	0.00734	CbGeAlD
Ritonavir—CYP2D6—female reproductive system—urinary bladder cancer	0.000329	0.00722	CbGeAlD
Ritonavir—ABCB1—epithelium—urinary bladder cancer	0.000318	0.00699	CbGeAlD
Ritonavir—ABCB1—renal system—urinary bladder cancer	0.000295	0.00648	CbGeAlD
Ritonavir—ABCB1—urethra—urinary bladder cancer	0.00029	0.00637	CbGeAlD
Ritonavir—ABCG2—lymph node—urinary bladder cancer	0.000281	0.00616	CbGeAlD
Ritonavir—ABCB1—female reproductive system—urinary bladder cancer	0.000237	0.00519	CbGeAlD
Ritonavir—ABCB1—vagina—urinary bladder cancer	0.000214	0.0047	CbGeAlD
Ritonavir—ABCB1—lymph node—urinary bladder cancer	0.000138	0.00304	CbGeAlD
Ritonavir—Hypoaesthesia—Epirubicin—urinary bladder cancer	8.01e-05	0.000392	CcSEcCtD
Ritonavir—Asthenia—Cisplatin—urinary bladder cancer	7.99e-05	0.000392	CcSEcCtD
Ritonavir—Pharyngitis—Epirubicin—urinary bladder cancer	7.99e-05	0.000391	CcSEcCtD
Ritonavir—Cardiac disorder—Methotrexate—urinary bladder cancer	7.98e-05	0.000391	CcSEcCtD
Ritonavir—Sweating—Doxorubicin—urinary bladder cancer	7.95e-05	0.00039	CcSEcCtD
Ritonavir—Urinary tract disorder—Epirubicin—urinary bladder cancer	7.95e-05	0.00039	CcSEcCtD
Ritonavir—Oedema peripheral—Epirubicin—urinary bladder cancer	7.93e-05	0.000389	CcSEcCtD
Ritonavir—Haematuria—Doxorubicin—urinary bladder cancer	7.91e-05	0.000388	CcSEcCtD
Ritonavir—Connective tissue disorder—Epirubicin—urinary bladder cancer	7.91e-05	0.000388	CcSEcCtD
Ritonavir—Urethral disorder—Epirubicin—urinary bladder cancer	7.89e-05	0.000387	CcSEcCtD
Ritonavir—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	7.85e-05	0.000385	CcSEcCtD
Ritonavir—Epistaxis—Doxorubicin—urinary bladder cancer	7.83e-05	0.000383	CcSEcCtD
Ritonavir—Angiopathy—Methotrexate—urinary bladder cancer	7.8e-05	0.000382	CcSEcCtD
Ritonavir—Sinusitis—Doxorubicin—urinary bladder cancer	7.78e-05	0.000381	CcSEcCtD
Ritonavir—Immune system disorder—Methotrexate—urinary bladder cancer	7.77e-05	0.000381	CcSEcCtD
Ritonavir—Dizziness—Fluorouracil—urinary bladder cancer	7.77e-05	0.000381	CcSEcCtD
Ritonavir—Visual impairment—Epirubicin—urinary bladder cancer	7.76e-05	0.00038	CcSEcCtD
Ritonavir—Mediastinal disorder—Methotrexate—urinary bladder cancer	7.75e-05	0.00038	CcSEcCtD
Ritonavir—Chills—Methotrexate—urinary bladder cancer	7.72e-05	0.000378	CcSEcCtD
Ritonavir—Diarrhoea—Cisplatin—urinary bladder cancer	7.62e-05	0.000373	CcSEcCtD
Ritonavir—Erythema multiforme—Epirubicin—urinary bladder cancer	7.61e-05	0.000373	CcSEcCtD
Ritonavir—Vomiting—Gemcitabine—urinary bladder cancer	7.6e-05	0.000372	CcSEcCtD
Ritonavir—Mental disorder—Methotrexate—urinary bladder cancer	7.54e-05	0.000369	CcSEcCtD
Ritonavir—Rash—Gemcitabine—urinary bladder cancer	7.53e-05	0.000369	CcSEcCtD
Ritonavir—Dermatitis—Gemcitabine—urinary bladder cancer	7.53e-05	0.000369	CcSEcCtD
Ritonavir—Eye disorder—Epirubicin—urinary bladder cancer	7.52e-05	0.000369	CcSEcCtD
Ritonavir—Hypersensitivity—Etoposide—urinary bladder cancer	7.52e-05	0.000368	CcSEcCtD
Ritonavir—Tinnitus—Epirubicin—urinary bladder cancer	7.51e-05	0.000368	CcSEcCtD
Ritonavir—Malnutrition—Methotrexate—urinary bladder cancer	7.49e-05	0.000367	CcSEcCtD
Ritonavir—Haemoglobin—Doxorubicin—urinary bladder cancer	7.49e-05	0.000367	CcSEcCtD
Ritonavir—Headache—Gemcitabine—urinary bladder cancer	7.49e-05	0.000367	CcSEcCtD
Ritonavir—Flushing—Epirubicin—urinary bladder cancer	7.47e-05	0.000366	CcSEcCtD
Ritonavir—Cardiac disorder—Epirubicin—urinary bladder cancer	7.47e-05	0.000366	CcSEcCtD
Ritonavir—Vomiting—Fluorouracil—urinary bladder cancer	7.47e-05	0.000366	CcSEcCtD
Ritonavir—Rhinitis—Doxorubicin—urinary bladder cancer	7.47e-05	0.000366	CcSEcCtD
Ritonavir—Haemorrhage—Doxorubicin—urinary bladder cancer	7.45e-05	0.000365	CcSEcCtD
Ritonavir—Hepatitis—Doxorubicin—urinary bladder cancer	7.45e-05	0.000365	CcSEcCtD
Ritonavir—Hypoaesthesia—Doxorubicin—urinary bladder cancer	7.41e-05	0.000363	CcSEcCtD
Ritonavir—Rash—Fluorouracil—urinary bladder cancer	7.41e-05	0.000363	CcSEcCtD
Ritonavir—Dermatitis—Fluorouracil—urinary bladder cancer	7.4e-05	0.000363	CcSEcCtD
Ritonavir—Pharyngitis—Doxorubicin—urinary bladder cancer	7.39e-05	0.000362	CcSEcCtD
Ritonavir—Headache—Fluorouracil—urinary bladder cancer	7.36e-05	0.000361	CcSEcCtD
Ritonavir—Urinary tract disorder—Doxorubicin—urinary bladder cancer	7.36e-05	0.00036	CcSEcCtD
Ritonavir—Oedema peripheral—Doxorubicin—urinary bladder cancer	7.34e-05	0.00036	CcSEcCtD
Ritonavir—Dysgeusia—Methotrexate—urinary bladder cancer	7.33e-05	0.000359	CcSEcCtD
Ritonavir—Asthenia—Etoposide—urinary bladder cancer	7.32e-05	0.000359	CcSEcCtD
Ritonavir—Connective tissue disorder—Doxorubicin—urinary bladder cancer	7.32e-05	0.000359	CcSEcCtD
Ritonavir—Angiopathy—Epirubicin—urinary bladder cancer	7.3e-05	0.000358	CcSEcCtD
Ritonavir—Urethral disorder—Doxorubicin—urinary bladder cancer	7.3e-05	0.000358	CcSEcCtD
Ritonavir—Immune system disorder—Epirubicin—urinary bladder cancer	7.27e-05	0.000356	CcSEcCtD
Ritonavir—Mediastinal disorder—Epirubicin—urinary bladder cancer	7.26e-05	0.000355	CcSEcCtD
Ritonavir—Back pain—Methotrexate—urinary bladder cancer	7.24e-05	0.000355	CcSEcCtD
Ritonavir—Chills—Epirubicin—urinary bladder cancer	7.22e-05	0.000354	CcSEcCtD
Ritonavir—Pruritus—Etoposide—urinary bladder cancer	7.22e-05	0.000354	CcSEcCtD
Ritonavir—Visual impairment—Doxorubicin—urinary bladder cancer	7.18e-05	0.000352	CcSEcCtD
Ritonavir—Nausea—Gemcitabine—urinary bladder cancer	7.1e-05	0.000348	CcSEcCtD
Ritonavir—Vomiting—Cisplatin—urinary bladder cancer	7.08e-05	0.000347	CcSEcCtD
Ritonavir—Vision blurred—Methotrexate—urinary bladder cancer	7.06e-05	0.000346	CcSEcCtD
Ritonavir—Mental disorder—Epirubicin—urinary bladder cancer	7.05e-05	0.000346	CcSEcCtD
Ritonavir—Erythema multiforme—Doxorubicin—urinary bladder cancer	7.04e-05	0.000345	CcSEcCtD
Ritonavir—Rash—Cisplatin—urinary bladder cancer	7.02e-05	0.000344	CcSEcCtD
Ritonavir—Dermatitis—Cisplatin—urinary bladder cancer	7.02e-05	0.000344	CcSEcCtD
Ritonavir—Malnutrition—Epirubicin—urinary bladder cancer	7.01e-05	0.000343	CcSEcCtD
Ritonavir—Diarrhoea—Etoposide—urinary bladder cancer	6.98e-05	0.000342	CcSEcCtD
Ritonavir—Nausea—Fluorouracil—urinary bladder cancer	6.98e-05	0.000342	CcSEcCtD
Ritonavir—Eye disorder—Doxorubicin—urinary bladder cancer	6.96e-05	0.000341	CcSEcCtD
Ritonavir—Ill-defined disorder—Methotrexate—urinary bladder cancer	6.95e-05	0.00034	CcSEcCtD
Ritonavir—Tinnitus—Doxorubicin—urinary bladder cancer	6.95e-05	0.00034	CcSEcCtD
Ritonavir—Anaemia—Methotrexate—urinary bladder cancer	6.92e-05	0.000339	CcSEcCtD
Ritonavir—Flushing—Doxorubicin—urinary bladder cancer	6.91e-05	0.000339	CcSEcCtD
Ritonavir—Cardiac disorder—Doxorubicin—urinary bladder cancer	6.91e-05	0.000339	CcSEcCtD
Ritonavir—Flatulence—Epirubicin—urinary bladder cancer	6.91e-05	0.000338	CcSEcCtD
Ritonavir—Tension—Epirubicin—urinary bladder cancer	6.88e-05	0.000337	CcSEcCtD
Ritonavir—Dysgeusia—Epirubicin—urinary bladder cancer	6.86e-05	0.000336	CcSEcCtD
Ritonavir—Nervousness—Epirubicin—urinary bladder cancer	6.81e-05	0.000334	CcSEcCtD
Ritonavir—Back pain—Epirubicin—urinary bladder cancer	6.78e-05	0.000332	CcSEcCtD
Ritonavir—Angiopathy—Doxorubicin—urinary bladder cancer	6.76e-05	0.000331	CcSEcCtD
Ritonavir—Malaise—Methotrexate—urinary bladder cancer	6.75e-05	0.000331	CcSEcCtD
Ritonavir—Dizziness—Etoposide—urinary bladder cancer	6.75e-05	0.000331	CcSEcCtD
Ritonavir—Muscle spasms—Epirubicin—urinary bladder cancer	6.74e-05	0.00033	CcSEcCtD
Ritonavir—Immune system disorder—Doxorubicin—urinary bladder cancer	6.73e-05	0.00033	CcSEcCtD
Ritonavir—Vertigo—Methotrexate—urinary bladder cancer	6.73e-05	0.00033	CcSEcCtD
Ritonavir—Mediastinal disorder—Doxorubicin—urinary bladder cancer	6.71e-05	0.000329	CcSEcCtD
Ritonavir—Leukopenia—Methotrexate—urinary bladder cancer	6.7e-05	0.000328	CcSEcCtD
Ritonavir—Chills—Doxorubicin—urinary bladder cancer	6.68e-05	0.000327	CcSEcCtD
Ritonavir—Nausea—Cisplatin—urinary bladder cancer	6.62e-05	0.000324	CcSEcCtD
Ritonavir—Vision blurred—Epirubicin—urinary bladder cancer	6.6e-05	0.000324	CcSEcCtD
Ritonavir—Cough—Methotrexate—urinary bladder cancer	6.53e-05	0.00032	CcSEcCtD
Ritonavir—Mental disorder—Doxorubicin—urinary bladder cancer	6.53e-05	0.00032	CcSEcCtD
Ritonavir—Ill-defined disorder—Epirubicin—urinary bladder cancer	6.5e-05	0.000319	CcSEcCtD
Ritonavir—Convulsion—Methotrexate—urinary bladder cancer	6.49e-05	0.000318	CcSEcCtD
Ritonavir—Vomiting—Etoposide—urinary bladder cancer	6.49e-05	0.000318	CcSEcCtD
Ritonavir—Malnutrition—Doxorubicin—urinary bladder cancer	6.48e-05	0.000318	CcSEcCtD
Ritonavir—Anaemia—Epirubicin—urinary bladder cancer	6.48e-05	0.000317	CcSEcCtD
Ritonavir—Agitation—Epirubicin—urinary bladder cancer	6.44e-05	0.000316	CcSEcCtD
Ritonavir—Rash—Etoposide—urinary bladder cancer	6.43e-05	0.000315	CcSEcCtD
Ritonavir—Dermatitis—Etoposide—urinary bladder cancer	6.43e-05	0.000315	CcSEcCtD
Ritonavir—Headache—Etoposide—urinary bladder cancer	6.39e-05	0.000313	CcSEcCtD
Ritonavir—Flatulence—Doxorubicin—urinary bladder cancer	6.39e-05	0.000313	CcSEcCtD
Ritonavir—Myalgia—Methotrexate—urinary bladder cancer	6.38e-05	0.000312	CcSEcCtD
Ritonavir—Chest pain—Methotrexate—urinary bladder cancer	6.38e-05	0.000312	CcSEcCtD
Ritonavir—Arthralgia—Methotrexate—urinary bladder cancer	6.38e-05	0.000312	CcSEcCtD
Ritonavir—Tension—Doxorubicin—urinary bladder cancer	6.36e-05	0.000312	CcSEcCtD
Ritonavir—Dysgeusia—Doxorubicin—urinary bladder cancer	6.35e-05	0.000311	CcSEcCtD
Ritonavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	6.33e-05	0.00031	CcSEcCtD
Ritonavir—Malaise—Epirubicin—urinary bladder cancer	6.32e-05	0.00031	CcSEcCtD
Ritonavir—Discomfort—Methotrexate—urinary bladder cancer	6.3e-05	0.000309	CcSEcCtD
Ritonavir—Nervousness—Doxorubicin—urinary bladder cancer	6.3e-05	0.000309	CcSEcCtD
Ritonavir—Vertigo—Epirubicin—urinary bladder cancer	6.3e-05	0.000309	CcSEcCtD
Ritonavir—Syncope—Epirubicin—urinary bladder cancer	6.28e-05	0.000308	CcSEcCtD
Ritonavir—Leukopenia—Epirubicin—urinary bladder cancer	6.27e-05	0.000307	CcSEcCtD
Ritonavir—Back pain—Doxorubicin—urinary bladder cancer	6.27e-05	0.000307	CcSEcCtD
Ritonavir—Muscle spasms—Doxorubicin—urinary bladder cancer	6.23e-05	0.000305	CcSEcCtD
Ritonavir—Palpitations—Epirubicin—urinary bladder cancer	6.19e-05	0.000303	CcSEcCtD
Ritonavir—Confusional state—Methotrexate—urinary bladder cancer	6.16e-05	0.000302	CcSEcCtD
Ritonavir—Loss of consciousness—Epirubicin—urinary bladder cancer	6.16e-05	0.000302	CcSEcCtD
Ritonavir—Cough—Epirubicin—urinary bladder cancer	6.12e-05	0.0003	CcSEcCtD
Ritonavir—Vision blurred—Doxorubicin—urinary bladder cancer	6.11e-05	0.000299	CcSEcCtD
Ritonavir—Convulsion—Epirubicin—urinary bladder cancer	6.07e-05	0.000298	CcSEcCtD
Ritonavir—Nausea—Etoposide—urinary bladder cancer	6.06e-05	0.000297	CcSEcCtD
Ritonavir—Hypertension—Epirubicin—urinary bladder cancer	6.05e-05	0.000296	CcSEcCtD
Ritonavir—Ill-defined disorder—Doxorubicin—urinary bladder cancer	6.02e-05	0.000295	CcSEcCtD
Ritonavir—Nervous system disorder—Methotrexate—urinary bladder cancer	5.99e-05	0.000294	CcSEcCtD
Ritonavir—Anaemia—Doxorubicin—urinary bladder cancer	5.99e-05	0.000294	CcSEcCtD
Ritonavir—Thrombocytopenia—Methotrexate—urinary bladder cancer	5.98e-05	0.000293	CcSEcCtD
Ritonavir—Myalgia—Epirubicin—urinary bladder cancer	5.97e-05	0.000292	CcSEcCtD
Ritonavir—Arthralgia—Epirubicin—urinary bladder cancer	5.97e-05	0.000292	CcSEcCtD
Ritonavir—Chest pain—Epirubicin—urinary bladder cancer	5.97e-05	0.000292	CcSEcCtD
Ritonavir—Agitation—Doxorubicin—urinary bladder cancer	5.96e-05	0.000292	CcSEcCtD
Ritonavir—Anxiety—Epirubicin—urinary bladder cancer	5.95e-05	0.000291	CcSEcCtD
Ritonavir—Skin disorder—Methotrexate—urinary bladder cancer	5.94e-05	0.000291	CcSEcCtD
Ritonavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	5.93e-05	0.00029	CcSEcCtD
Ritonavir—Hyperhidrosis—Methotrexate—urinary bladder cancer	5.91e-05	0.000289	CcSEcCtD
Ritonavir—Discomfort—Epirubicin—urinary bladder cancer	5.89e-05	0.000289	CcSEcCtD
Ritonavir—Malaise—Doxorubicin—urinary bladder cancer	5.85e-05	0.000287	CcSEcCtD
Ritonavir—Dry mouth—Epirubicin—urinary bladder cancer	5.84e-05	0.000286	CcSEcCtD
Ritonavir—Vertigo—Doxorubicin—urinary bladder cancer	5.83e-05	0.000285	CcSEcCtD
Ritonavir—Anorexia—Methotrexate—urinary bladder cancer	5.83e-05	0.000285	CcSEcCtD
Ritonavir—Syncope—Doxorubicin—urinary bladder cancer	5.82e-05	0.000285	CcSEcCtD
Ritonavir—Leukopenia—Doxorubicin—urinary bladder cancer	5.8e-05	0.000284	CcSEcCtD
Ritonavir—Confusional state—Epirubicin—urinary bladder cancer	5.77e-05	0.000283	CcSEcCtD
Ritonavir—Palpitations—Doxorubicin—urinary bladder cancer	5.73e-05	0.000281	CcSEcCtD
Ritonavir—Oedema—Epirubicin—urinary bladder cancer	5.72e-05	0.00028	CcSEcCtD
Ritonavir—Hypotension—Methotrexate—urinary bladder cancer	5.71e-05	0.00028	CcSEcCtD
Ritonavir—Loss of consciousness—Doxorubicin—urinary bladder cancer	5.7e-05	0.000279	CcSEcCtD
Ritonavir—Cough—Doxorubicin—urinary bladder cancer	5.66e-05	0.000277	CcSEcCtD
Ritonavir—Shock—Epirubicin—urinary bladder cancer	5.63e-05	0.000276	CcSEcCtD
Ritonavir—Convulsion—Doxorubicin—urinary bladder cancer	5.62e-05	0.000275	CcSEcCtD
Ritonavir—Nervous system disorder—Epirubicin—urinary bladder cancer	5.61e-05	0.000275	CcSEcCtD
Ritonavir—Thrombocytopenia—Epirubicin—urinary bladder cancer	5.6e-05	0.000274	CcSEcCtD
Ritonavir—Hypertension—Doxorubicin—urinary bladder cancer	5.6e-05	0.000274	CcSEcCtD
Ritonavir—Tachycardia—Epirubicin—urinary bladder cancer	5.58e-05	0.000274	CcSEcCtD
Ritonavir—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	5.57e-05	0.000273	CcSEcCtD
Ritonavir—Skin disorder—Epirubicin—urinary bladder cancer	5.56e-05	0.000272	CcSEcCtD
Ritonavir—Hyperhidrosis—Epirubicin—urinary bladder cancer	5.53e-05	0.000271	CcSEcCtD
Ritonavir—Insomnia—Methotrexate—urinary bladder cancer	5.53e-05	0.000271	CcSEcCtD
Ritonavir—Myalgia—Doxorubicin—urinary bladder cancer	5.52e-05	0.00027	CcSEcCtD
Ritonavir—Arthralgia—Doxorubicin—urinary bladder cancer	5.52e-05	0.00027	CcSEcCtD
Ritonavir—Chest pain—Doxorubicin—urinary bladder cancer	5.52e-05	0.00027	CcSEcCtD
Ritonavir—Anxiety—Doxorubicin—urinary bladder cancer	5.5e-05	0.00027	CcSEcCtD
Ritonavir—Paraesthesia—Methotrexate—urinary bladder cancer	5.49e-05	0.000269	CcSEcCtD
Ritonavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	5.48e-05	0.000269	CcSEcCtD
Ritonavir—Discomfort—Doxorubicin—urinary bladder cancer	5.45e-05	0.000267	CcSEcCtD
Ritonavir—Anorexia—Epirubicin—urinary bladder cancer	5.45e-05	0.000267	CcSEcCtD
Ritonavir—Dyspnoea—Methotrexate—urinary bladder cancer	5.45e-05	0.000267	CcSEcCtD
Ritonavir—Somnolence—Methotrexate—urinary bladder cancer	5.43e-05	0.000266	CcSEcCtD
Ritonavir—Dry mouth—Doxorubicin—urinary bladder cancer	5.4e-05	0.000265	CcSEcCtD
Ritonavir—Dyspepsia—Methotrexate—urinary bladder cancer	5.38e-05	0.000264	CcSEcCtD
Ritonavir—Hypotension—Epirubicin—urinary bladder cancer	5.34e-05	0.000262	CcSEcCtD
Ritonavir—Confusional state—Doxorubicin—urinary bladder cancer	5.34e-05	0.000261	CcSEcCtD
Ritonavir—Decreased appetite—Methotrexate—urinary bladder cancer	5.31e-05	0.00026	CcSEcCtD
Ritonavir—Oedema—Doxorubicin—urinary bladder cancer	5.29e-05	0.000259	CcSEcCtD
Ritonavir—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	5.28e-05	0.000259	CcSEcCtD
Ritonavir—Fatigue—Methotrexate—urinary bladder cancer	5.27e-05	0.000258	CcSEcCtD
Ritonavir—Pain—Methotrexate—urinary bladder cancer	5.23e-05	0.000256	CcSEcCtD
Ritonavir—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	5.21e-05	0.000255	CcSEcCtD
Ritonavir—Shock—Doxorubicin—urinary bladder cancer	5.21e-05	0.000255	CcSEcCtD
Ritonavir—Nervous system disorder—Doxorubicin—urinary bladder cancer	5.19e-05	0.000254	CcSEcCtD
Ritonavir—Thrombocytopenia—Doxorubicin—urinary bladder cancer	5.18e-05	0.000254	CcSEcCtD
Ritonavir—Insomnia—Epirubicin—urinary bladder cancer	5.17e-05	0.000253	CcSEcCtD
Ritonavir—Tachycardia—Doxorubicin—urinary bladder cancer	5.17e-05	0.000253	CcSEcCtD
Ritonavir—Skin disorder—Doxorubicin—urinary bladder cancer	5.14e-05	0.000252	CcSEcCtD
Ritonavir—Paraesthesia—Epirubicin—urinary bladder cancer	5.14e-05	0.000252	CcSEcCtD
Ritonavir—Hyperhidrosis—Doxorubicin—urinary bladder cancer	5.12e-05	0.000251	CcSEcCtD
Ritonavir—Dyspnoea—Epirubicin—urinary bladder cancer	5.1e-05	0.00025	CcSEcCtD
Ritonavir—Somnolence—Epirubicin—urinary bladder cancer	5.08e-05	0.000249	CcSEcCtD
Ritonavir—Anorexia—Doxorubicin—urinary bladder cancer	5.04e-05	0.000247	CcSEcCtD
Ritonavir—Feeling abnormal—Methotrexate—urinary bladder cancer	5.04e-05	0.000247	CcSEcCtD
Ritonavir—Dyspepsia—Epirubicin—urinary bladder cancer	5.03e-05	0.000247	CcSEcCtD
Ritonavir—Gastrointestinal pain—Methotrexate—urinary bladder cancer	5e-05	0.000245	CcSEcCtD
Ritonavir—Decreased appetite—Epirubicin—urinary bladder cancer	4.97e-05	0.000244	CcSEcCtD
Ritonavir—Hypotension—Doxorubicin—urinary bladder cancer	4.95e-05	0.000242	CcSEcCtD
Ritonavir—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	4.94e-05	0.000242	CcSEcCtD
Ritonavir—Fatigue—Epirubicin—urinary bladder cancer	4.93e-05	0.000242	CcSEcCtD
Ritonavir—Pain—Epirubicin—urinary bladder cancer	4.89e-05	0.00024	CcSEcCtD
Ritonavir—Constipation—Epirubicin—urinary bladder cancer	4.89e-05	0.00024	CcSEcCtD
Ritonavir—Urticaria—Methotrexate—urinary bladder cancer	4.86e-05	0.000238	CcSEcCtD
Ritonavir—Body temperature increased—Methotrexate—urinary bladder cancer	4.83e-05	0.000237	CcSEcCtD
Ritonavir—Abdominal pain—Methotrexate—urinary bladder cancer	4.83e-05	0.000237	CcSEcCtD
Ritonavir—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	4.82e-05	0.000236	CcSEcCtD
Ritonavir—Insomnia—Doxorubicin—urinary bladder cancer	4.79e-05	0.000235	CcSEcCtD
Ritonavir—Paraesthesia—Doxorubicin—urinary bladder cancer	4.75e-05	0.000233	CcSEcCtD
Ritonavir—Dyspnoea—Doxorubicin—urinary bladder cancer	4.72e-05	0.000231	CcSEcCtD
Ritonavir—Feeling abnormal—Epirubicin—urinary bladder cancer	4.71e-05	0.000231	CcSEcCtD
Ritonavir—Somnolence—Doxorubicin—urinary bladder cancer	4.7e-05	0.000231	CcSEcCtD
Ritonavir—Gastrointestinal pain—Epirubicin—urinary bladder cancer	4.68e-05	0.000229	CcSEcCtD
Ritonavir—Dyspepsia—Doxorubicin—urinary bladder cancer	4.66e-05	0.000228	CcSEcCtD
Ritonavir—Decreased appetite—Doxorubicin—urinary bladder cancer	4.6e-05	0.000225	CcSEcCtD
Ritonavir—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	4.57e-05	0.000224	CcSEcCtD
Ritonavir—Fatigue—Doxorubicin—urinary bladder cancer	4.56e-05	0.000224	CcSEcCtD
Ritonavir—Urticaria—Epirubicin—urinary bladder cancer	4.54e-05	0.000223	CcSEcCtD
Ritonavir—Pain—Doxorubicin—urinary bladder cancer	4.53e-05	0.000222	CcSEcCtD
Ritonavir—Constipation—Doxorubicin—urinary bladder cancer	4.53e-05	0.000222	CcSEcCtD
Ritonavir—Body temperature increased—Epirubicin—urinary bladder cancer	4.52e-05	0.000222	CcSEcCtD
Ritonavir—Abdominal pain—Epirubicin—urinary bladder cancer	4.52e-05	0.000222	CcSEcCtD
Ritonavir—Hypersensitivity—Methotrexate—urinary bladder cancer	4.5e-05	0.000221	CcSEcCtD
Ritonavir—Asthenia—Methotrexate—urinary bladder cancer	4.39e-05	0.000215	CcSEcCtD
Ritonavir—Feeling abnormal—Doxorubicin—urinary bladder cancer	4.36e-05	0.000214	CcSEcCtD
Ritonavir—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	4.33e-05	0.000212	CcSEcCtD
Ritonavir—Pruritus—Methotrexate—urinary bladder cancer	4.32e-05	0.000212	CcSEcCtD
Ritonavir—Hypersensitivity—Epirubicin—urinary bladder cancer	4.21e-05	0.000206	CcSEcCtD
Ritonavir—Urticaria—Doxorubicin—urinary bladder cancer	4.2e-05	0.000206	CcSEcCtD
Ritonavir—Abdominal pain—Doxorubicin—urinary bladder cancer	4.18e-05	0.000205	CcSEcCtD
Ritonavir—Body temperature increased—Doxorubicin—urinary bladder cancer	4.18e-05	0.000205	CcSEcCtD
Ritonavir—Diarrhoea—Methotrexate—urinary bladder cancer	4.18e-05	0.000205	CcSEcCtD
Ritonavir—Asthenia—Epirubicin—urinary bladder cancer	4.1e-05	0.000201	CcSEcCtD
Ritonavir—Pruritus—Epirubicin—urinary bladder cancer	4.05e-05	0.000198	CcSEcCtD
Ritonavir—Dizziness—Methotrexate—urinary bladder cancer	4.04e-05	0.000198	CcSEcCtD
Ritonavir—Diarrhoea—Epirubicin—urinary bladder cancer	3.91e-05	0.000192	CcSEcCtD
Ritonavir—Hypersensitivity—Doxorubicin—urinary bladder cancer	3.9e-05	0.000191	CcSEcCtD
Ritonavir—Vomiting—Methotrexate—urinary bladder cancer	3.89e-05	0.00019	CcSEcCtD
Ritonavir—Rash—Methotrexate—urinary bladder cancer	3.85e-05	0.000189	CcSEcCtD
Ritonavir—Dermatitis—Methotrexate—urinary bladder cancer	3.85e-05	0.000189	CcSEcCtD
Ritonavir—Headache—Methotrexate—urinary bladder cancer	3.83e-05	0.000188	CcSEcCtD
Ritonavir—Asthenia—Doxorubicin—urinary bladder cancer	3.8e-05	0.000186	CcSEcCtD
Ritonavir—Dizziness—Epirubicin—urinary bladder cancer	3.78e-05	0.000185	CcSEcCtD
Ritonavir—Pruritus—Doxorubicin—urinary bladder cancer	3.74e-05	0.000183	CcSEcCtD
Ritonavir—Vomiting—Epirubicin—urinary bladder cancer	3.64e-05	0.000178	CcSEcCtD
Ritonavir—Nausea—Methotrexate—urinary bladder cancer	3.63e-05	0.000178	CcSEcCtD
Ritonavir—Diarrhoea—Doxorubicin—urinary bladder cancer	3.62e-05	0.000177	CcSEcCtD
Ritonavir—Rash—Epirubicin—urinary bladder cancer	3.61e-05	0.000177	CcSEcCtD
Ritonavir—Dermatitis—Epirubicin—urinary bladder cancer	3.6e-05	0.000177	CcSEcCtD
Ritonavir—Headache—Epirubicin—urinary bladder cancer	3.58e-05	0.000176	CcSEcCtD
Ritonavir—Dizziness—Doxorubicin—urinary bladder cancer	3.5e-05	0.000171	CcSEcCtD
Ritonavir—Nausea—Epirubicin—urinary bladder cancer	3.4e-05	0.000166	CcSEcCtD
Ritonavir—Vomiting—Doxorubicin—urinary bladder cancer	3.36e-05	0.000165	CcSEcCtD
Ritonavir—Rash—Doxorubicin—urinary bladder cancer	3.34e-05	0.000163	CcSEcCtD
Ritonavir—Dermatitis—Doxorubicin—urinary bladder cancer	3.33e-05	0.000163	CcSEcCtD
Ritonavir—Headache—Doxorubicin—urinary bladder cancer	3.32e-05	0.000162	CcSEcCtD
Ritonavir—Nausea—Doxorubicin—urinary bladder cancer	3.14e-05	0.000154	CcSEcCtD
Ritonavir—ABCG2—Metabolism—GSTP1—urinary bladder cancer	1.32e-05	0.000142	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.32e-05	0.000142	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—RRM2—urinary bladder cancer	1.32e-05	0.000142	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—NCOR1—urinary bladder cancer	1.31e-05	0.000141	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—GSTM1—urinary bladder cancer	1.31e-05	0.000141	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	1.31e-05	0.000141	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—ERCC2—urinary bladder cancer	1.3e-05	0.00014	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—GPX1—urinary bladder cancer	1.25e-05	0.000135	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—NAT2—urinary bladder cancer	1.25e-05	0.000135	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—NAT2—urinary bladder cancer	1.24e-05	0.000134	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—ERCC2—urinary bladder cancer	1.23e-05	0.000133	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	1.23e-05	0.000133	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—TYMS—urinary bladder cancer	1.23e-05	0.000132	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—ENO2—urinary bladder cancer	1.22e-05	0.000131	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	1.22e-05	0.000131	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—MTHFR—urinary bladder cancer	1.22e-05	0.000131	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—TYMS—urinary bladder cancer	1.22e-05	0.000131	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—NCOR1—urinary bladder cancer	1.21e-05	0.000131	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—GSTM1—urinary bladder cancer	1.21e-05	0.000131	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.21e-05	0.000131	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	1.2e-05	0.00013	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	1.2e-05	0.00013	CbGpPWpGaD
Ritonavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	1.18e-05	0.000128	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	1.18e-05	0.000128	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.18e-05	0.000127	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—RRM2—urinary bladder cancer	1.17e-05	0.000127	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—TYMP—urinary bladder cancer	1.17e-05	0.000126	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.16e-05	0.000126	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—GPX1—urinary bladder cancer	1.16e-05	0.000125	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.16e-05	0.000125	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—NQO1—urinary bladder cancer	1.16e-05	0.000125	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—MTHFR—urinary bladder cancer	1.16e-05	0.000125	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—GPX1—urinary bladder cancer	1.15e-05	0.000124	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.15e-05	0.000124	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—ERCC2—urinary bladder cancer	1.14e-05	0.000123	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—NQO1—urinary bladder cancer	1.14e-05	0.000123	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—NQO1—urinary bladder cancer	1.13e-05	0.000122	CbGpPWpGaD
Ritonavir—ABCC1—Disease—CREBBP—urinary bladder cancer	1.13e-05	0.000122	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.13e-05	0.000122	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	1.13e-05	0.000122	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.13e-05	0.000121	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	1.1e-05	0.000118	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	1.09e-05	0.000117	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—ENO2—urinary bladder cancer	1.09e-05	0.000117	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.08e-05	0.000117	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.08e-05	0.000117	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—MTHFR—urinary bladder cancer	1.07e-05	0.000116	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.07e-05	0.000116	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	1.06e-05	0.000115	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.06e-05	0.000115	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.06e-05	0.000115	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—NAT2—urinary bladder cancer	1.06e-05	0.000114	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	1.05e-05	0.000114	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	1.05e-05	0.000114	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.04e-05	0.000112	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.03e-05	0.000111	CbGpPWpGaD
Ritonavir—ABCC1—Disease—RHOA—urinary bladder cancer	1.03e-05	0.000111	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1e-05	0.000108	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1e-05	0.000108	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	9.92e-06	0.000107	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—ENO2—urinary bladder cancer	9.92e-06	0.000107	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—PPARG—urinary bladder cancer	9.88e-06	0.000107	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	9.86e-06	0.000106	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—NQO1—urinary bladder cancer	9.82e-06	0.000106	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	9.7e-06	0.000105	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	9.68e-06	0.000104	CbGpPWpGaD
Ritonavir—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.64e-06	0.000104	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	9.62e-06	0.000104	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	9.53e-06	0.000103	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—CREBBP—urinary bladder cancer	9.49e-06	0.000102	CbGpPWpGaD
Ritonavir—ABCC1—Disease—ERBB2—urinary bladder cancer	9.49e-06	0.000102	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	9.48e-06	0.000102	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	9.47e-06	0.000102	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	9.46e-06	0.000102	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—PPARG—urinary bladder cancer	9.39e-06	0.000101	CbGpPWpGaD
Ritonavir—ABCC1—Disease—PTGS2—urinary bladder cancer	9.28e-06	0.0001	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—RRM2—urinary bladder cancer	9.15e-06	9.88e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—TYMP—urinary bladder cancer	9.05e-06	9.76e-05	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—CREBBP—urinary bladder cancer	9.02e-06	9.73e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—TYMS—urinary bladder cancer	9e-06	9.71e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	8.89e-06	9.6e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	8.89e-06	9.6e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—TYMS—urinary bladder cancer	8.81e-06	9.51e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—TYMS—urinary bladder cancer	8.79e-06	9.49e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—NQO1—urinary bladder cancer	8.77e-06	9.46e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	8.71e-06	9.4e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	8.71e-06	9.4e-05	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—PPARG—urinary bladder cancer	8.69e-06	9.38e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	8.69e-06	9.38e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	8.69e-06	9.38e-05	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	8.64e-06	9.32e-05	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—PPARG—urinary bladder cancer	8.62e-06	9.3e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—NQO1—urinary bladder cancer	8.56e-06	9.23e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—GPX1—urinary bladder cancer	8.52e-06	9.19e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.51e-06	9.18e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	8.47e-06	9.15e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—ENO2—urinary bladder cancer	8.47e-06	9.15e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.43e-06	9.09e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	8.36e-06	9.02e-05	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—CREBBP—urinary bladder cancer	8.35e-06	9.01e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—GPX1—urinary bladder cancer	8.34e-06	9e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—GPX1—urinary bladder cancer	8.32e-06	8.98e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.31e-06	8.97e-05	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	8.28e-06	8.93e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	8.22e-06	8.87e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	8.19e-06	8.84e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	8.19e-06	8.84e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—NAT2—urinary bladder cancer	8.18e-06	8.83e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	8.17e-06	8.82e-05	CbGpPWpGaD
Ritonavir—ABCC1—Disease—CDKN1A—urinary bladder cancer	8.11e-06	8.75e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.09e-06	8.73e-05	CbGpPWpGaD
Ritonavir—ABCC1—Disease—PTEN—urinary bladder cancer	8.09e-06	8.73e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—NQO1—urinary bladder cancer	8.06e-06	8.7e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—NQO1—urinary bladder cancer	7.99e-06	8.63e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.93e-06	8.55e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	7.86e-06	8.48e-05	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—PTGS2—urinary bladder cancer	7.77e-06	8.39e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.76e-06	8.37e-05	CbGpPWpGaD
Ritonavir—ABCC1—Disease—EP300—urinary bladder cancer	7.72e-06	8.33e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	7.7e-06	8.31e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	7.68e-06	8.29e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—TYMS—urinary bladder cancer	7.62e-06	8.22e-05	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	7.53e-06	8.13e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	7.53e-06	8.12e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	7.53e-06	8.12e-05	CbGpPWpGaD
Ritonavir—ABCC1—Disease—SRC—urinary bladder cancer	7.51e-06	8.1e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.42e-06	8.01e-05	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—PTGS2—urinary bladder cancer	7.39e-06	7.97e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	7.31e-06	7.89e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—GPX1—urinary bladder cancer	7.21e-06	7.78e-05	CbGpPWpGaD
Ritonavir—SLCO1A2—Metabolism—EP300—urinary bladder cancer	7.18e-06	7.75e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—GSTP1—urinary bladder cancer	7.14e-06	7.7e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	7.08e-06	7.64e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.07e-06	7.63e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—RRM2—urinary bladder cancer	7.06e-06	7.62e-05	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—PTGS2—urinary bladder cancer	6.84e-06	7.38e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—NQO1—urinary bladder cancer	6.83e-06	7.37e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—TYMS—urinary bladder cancer	6.8e-06	7.34e-05	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	6.78e-06	7.32e-05	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—PTEN—urinary bladder cancer	6.78e-06	7.31e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.76e-06	7.3e-05	CbGpPWpGaD
Ritonavir—ABCC1—Disease—MYC—urinary bladder cancer	6.73e-06	7.26e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	6.73e-06	7.26e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	6.72e-06	7.25e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	6.72e-06	7.25e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	6.67e-06	7.19e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	6.65e-06	7.18e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—TYMS—urinary bladder cancer	6.64e-06	7.16e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.63e-06	7.15e-05	CbGpPWpGaD
Ritonavir—ABCC1—Disease—EGFR—urinary bladder cancer	6.58e-06	7.1e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—NCOR1—urinary bladder cancer	6.56e-06	7.08e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—GSTM1—urinary bladder cancer	6.56e-06	7.08e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—ENO2—urinary bladder cancer	6.54e-06	7.06e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	6.54e-06	7.06e-05	CbGpPWpGaD
Ritonavir—ABCC1—Metabolism—EP300—urinary bladder cancer	6.46e-06	6.98e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.45e-06	6.96e-05	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—PTEN—urinary bladder cancer	6.44e-06	6.95e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—GPX1—urinary bladder cancer	6.43e-06	6.94e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—PPARG—urinary bladder cancer	6.37e-06	6.88e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	6.34e-06	6.85e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	6.32e-06	6.82e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—GPX1—urinary bladder cancer	6.28e-06	6.78e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—TYMS—urinary bladder cancer	6.25e-06	6.75e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—PPARG—urinary bladder cancer	6.24e-06	6.74e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—PPARG—urinary bladder cancer	6.23e-06	6.72e-05	CbGpPWpGaD
Ritonavir—ABCC1—Disease—KRAS—urinary bladder cancer	6.21e-06	6.71e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—TYMS—urinary bladder cancer	6.2e-06	6.69e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	6.18e-06	6.67e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	6.18e-06	6.67e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—ERCC2—urinary bladder cancer	6.17e-06	6.65e-05	CbGpPWpGaD
Ritonavir—SLCO1B1—Metabolism—EP300—urinary bladder cancer	6.14e-06	6.63e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	6.13e-06	6.61e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	6.13e-06	6.61e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	6.12e-06	6.61e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	6e-06	6.47e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	5.98e-06	6.46e-05	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—PTEN—urinary bladder cancer	5.96e-06	6.44e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	5.94e-06	6.41e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—GPX1—urinary bladder cancer	5.92e-06	6.39e-05	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—PTEN—urinary bladder cancer	5.91e-06	6.38e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—GPX1—urinary bladder cancer	5.87e-06	6.33e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	5.81e-06	6.27e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—MTHFR—urinary bladder cancer	5.8e-06	6.25e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.78e-06	6.24e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	5.76e-06	6.22e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	5.7e-06	6.15e-05	CbGpPWpGaD
Ritonavir—ABCG2—Metabolism—EP300—urinary bladder cancer	5.69e-06	6.14e-05	CbGpPWpGaD
Ritonavir—CYP3A7—Metabolism—EP300—urinary bladder cancer	5.64e-06	6.08e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.51e-06	5.95e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	5.46e-06	5.89e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	5.41e-06	5.84e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—PPARG—urinary bladder cancer	5.4e-06	5.82e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—TYMS—urinary bladder cancer	5.3e-06	5.72e-05	CbGpPWpGaD
Ritonavir—ABCC1—Disease—HRAS—urinary bladder cancer	5.28e-06	5.7e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—NQO1—urinary bladder cancer	5.27e-06	5.69e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	5.24e-06	5.65e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	5.24e-06	5.65e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	5.18e-06	5.59e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—GPX1—urinary bladder cancer	5.01e-06	5.41e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	5.01e-06	5.41e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	4.92e-06	5.31e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	4.91e-06	5.3e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	4.9e-06	5.29e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—PPARG—urinary bladder cancer	4.82e-06	5.2e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—PPARG—urinary bladder cancer	4.7e-06	5.07e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	4.63e-06	4.99e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	4.63e-06	4.99e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—CREBBP—urinary bladder cancer	4.52e-06	4.87e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—PPARG—urinary bladder cancer	4.43e-06	4.78e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	4.4e-06	4.75e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—PPARG—urinary bladder cancer	4.39e-06	4.74e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—PTEN—urinary bladder cancer	4.37e-06	4.72e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—PTEN—urinary bladder cancer	4.28e-06	4.62e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—PTEN—urinary bladder cancer	4.27e-06	4.61e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	4.25e-06	4.59e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	4.24e-06	4.58e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	4.22e-06	4.55e-05	CbGpPWpGaD
Ritonavir—CYP2B6—Metabolism—EP300—urinary bladder cancer	4.17e-06	4.5e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—TYMS—urinary bladder cancer	4.09e-06	4.41e-05	CbGpPWpGaD
Ritonavir—CYP2E1—Metabolism—EP300—urinary bladder cancer	4.08e-06	4.41e-05	CbGpPWpGaD
Ritonavir—CYP3A5—Metabolism—EP300—urinary bladder cancer	4.08e-06	4.4e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	4.04e-06	4.36e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	4.04e-06	4.36e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—GPX1—urinary bladder cancer	3.87e-06	4.18e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	3.8e-06	4.1e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	3.79e-06	4.09e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—PPARG—urinary bladder cancer	3.75e-06	4.05e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—PTEN—urinary bladder cancer	3.7e-06	3.99e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—PTGS2—urinary bladder cancer	3.7e-06	3.99e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	3.6e-06	3.89e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	3.57e-06	3.85e-05	CbGpPWpGaD
Ritonavir—CYP2C8—Metabolism—EP300—urinary bladder cancer	3.53e-06	3.81e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	3.48e-06	3.76e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	3.45e-06	3.73e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—PTEN—urinary bladder cancer	3.3e-06	3.57e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—PTEN—urinary bladder cancer	3.22e-06	3.48e-05	CbGpPWpGaD
Ritonavir—CYP2C19—Metabolism—EP300—urinary bladder cancer	3.15e-06	3.4e-05	CbGpPWpGaD
Ritonavir—ABCB1—Metabolism—EP300—urinary bladder cancer	3.08e-06	3.32e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—PTEN—urinary bladder cancer	3.04e-06	3.28e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—PTEN—urinary bladder cancer	3.01e-06	3.25e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	2.95e-06	3.19e-05	CbGpPWpGaD
Ritonavir—CYP2D6—Metabolism—EP300—urinary bladder cancer	2.9e-06	3.13e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—PPARG—urinary bladder cancer	2.9e-06	3.12e-05	CbGpPWpGaD
Ritonavir—CYP2C9—Metabolism—EP300—urinary bladder cancer	2.87e-06	3.1e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	2.78e-06	3e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—PTEN—urinary bladder cancer	2.57e-06	2.78e-05	CbGpPWpGaD
Ritonavir—CYP1A2—Metabolism—EP300—urinary bladder cancer	2.45e-06	2.65e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	2.28e-06	2.46e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—PTEN—urinary bladder cancer	1.99e-06	2.14e-05	CbGpPWpGaD
Ritonavir—CYP3A4—Metabolism—EP300—urinary bladder cancer	1.89e-06	2.04e-05	CbGpPWpGaD
